InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.21
(
-0.46%
)
Bitcoin
61,147.98
(
0.60%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

HALF FULL GLASS

Send PM Follow Ignore
Followers 3
Posts 3535
Boards Moderated 0
Alias Born 06/15/2005

HALF FULL GLASS

Re: good-pal post# 1369

Tuesday, 10/04/2005 3:12:37 PM

Tuesday, October 04, 2005 3:12:37 PM

Post# of 30387
Good-pal,

Similar is acceptable. This is what the FDA wants to see. If one knows how a marker will react each time it is used, one can predict what is going on inside the tumor. This is fantastic news because the same person is not going to administer the test all over the world. As long as each test is similar + / - a specific accuracy tolerance then the product can be used as a universal marker. I would venture to say that the actual approved PSA tests are not identical each time. As long as they are similar this is good.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up